Cartesian Therapeutics Inc. (RNAC) — Cash Flow Reinvestment Rate
Cartesian Therapeutics Inc. (RNAC) has a Cash Flow Reinvestment Rate of 0.91x as of September 2024, reinvesting $12.40 Million (capex $6.20 Million plus investments $-6.20 Million) from operating cash flow of $13.69 Million. Explore capital reinvestment ratio of Cartesian Therapeutics Inc. to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cartesian Therapeutics Inc. Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Cartesian Therapeutics Inc. across 1 annual periods. Also explore RNAC total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Cartesian Therapeutics Inc. (2020–2020)
Year-by-year capital reinvestment analysis for Cartesian Therapeutics Inc.. For live market cap and broader valuation context, see Cartesian Therapeutics Inc. market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.04x | $1.56 Million | $34.88 Million | $815.00K | — |